HIV/AIDS: Transmission, Testing, Treatment & Stigma Reduction

What Is HIV/AIDS?

  • HIV (Human Immunodeficiency Virus): Retrovirus infecting CD4+ T cells → progressive immune decline.
  • AIDS (Acquired Immunodeficiency Syndrome): Clinical stage defined by CD4 <200 cells/μL or AIDS-defining illness (opportunistic infections, malignancies).

Transmission Routes

RouteRisk per Act (Est.)Prevention
Anal receptive sex1.4% (1/71)Condoms, PrEP, TasP, lubricant
Anal insertive sex0.11% (1/909)Condoms, PrEP, TasP
Vaginal receptive sex0.08% (1/1250)Condoms, PrEP, TasP
Vaginal insertive sex0.04% (1/2500)Condoms, PrEP, TasP
Needle sharing (IDU)0.63% (1/159)Syringe services, MOUD, PrEP
Mother-to-child (no intervention)15–45%ART in pregnancy, C-section if VL>1000, no breastfeeding (US)
Blood transfusion (screened)<1/1,000,000Nucleic acid testing (NAT) screening

No risk: Saliva, sweat, tears, urine, feces (unless blood-contaminated), casual contact, kissing (unless open sores), sharing food/toilets, insects.

Testing

  • 4th gen Ag/Ab: Detects p24 antigen + antibodies; window period 18–45 days.
  • NAT (RNA): Window 10–33 days; used for acute infection, blood screening.
  • Rapid Ab: Window 23–90 days; point-of-care.
  • Recommendation: Everyone 13–64 at least once; high-risk annually; pregnant each pregnancy.

Treatment: ART (Antiretroviral Therapy)

  • Goal: Viral suppression (<50 copies/mL) → immune recovery, zero transmission risk (U=U: Undetectable = Untransmittable).
  • Regimens: 2-drug (DTG/3TC, DRV/3TC) or 3-drug (BIC/FTC/TAF, DTG/ABC/3TC, DRV/c/FTC/TAF). Individualized.
  • Initiation: Rapid start (same day) preferred.
  • Monitoring: VL q3–6mo, CD4 q3–6mo (stop if VL suppressed & CD4>250), resistance if virologic failure.

Prevention

  • PrEP: TDF/FTC (daily), TAF/FTC (daily, MSM/TGW), Cabotegravir LA (bimonthly IM). >99% effective with adherence.
  • PEP: 28-day ART within 72h of exposure.
  • TasP: Treat positive partners to undetectable.
  • Syringe services, condoms, voluntary medical male circumcision (VMMC).

Stigma & Discrimination

  • Internalized, enacted, anticipated stigma → delayed testing, poor adherence, mental health burden.
  • Legal: 35 US states criminalize HIV non-disclosure/exposure (many outdated).
  • Combat: U=U messaging, person-first language ("person with HIV"), policy reform, community empowerment.

HIV is a manageable chronic condition. Early testing, immediate ART, and stigma-free care save lives and stop transmission.

HIV & AIDS - Related Articles